Cosette Pharmaceuticals acquires Ambien rights in US
Ambien CR (zolpidem tartrate extended-release tablets) is intended for the short-term management of insomnia, which is manifested by challenges in initiating sleep and/or maintaining sleep continuity. Ambien (zolpidem